United States · Venture startup

Who invested in Tellus Therapeutics

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$16Mraised across 1 round since 2023, from 1 source

Latest round
Venture, $16MFeb 2023
Investors
3
See who backed them

The rounds

  1. Feb 2023
    Venture$16M

    Source recordedSEC filing: $16M sold, first sale Nov 2022

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Tellus Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

XontogenyAcceleratorPer its own site

Quick answers about Tellus Therapeutics

Who invested in Tellus Therapeutics?

Tellus Therapeutics's investors include MassChallenge, One North Carolina Small Business Program and North Carolina Biotechnology Center.

How much has Tellus Therapeutics raised?

Tellus Therapeutics has raised $16M across 1 round since 2023.

When did Tellus Therapeutics last raise?

Tellus Therapeutics's most recent round was a Venture of $16M in Feb 2023.

What was Tellus Therapeutics's biggest round?

Its most recent round, $16M in Feb 2023, is also its largest on record.

Who backed Tellus Therapeutics first?

Tellus Therapeutics's first round on record, in Feb 2023, was backed by MassChallenge, One North Carolina Small Business Program and North Carolina Biotechnology Center.

What stage is Tellus Therapeutics at?

Tellus Therapeutics's latest named round is a Venture, in Feb 2023.

Where is Tellus Therapeutics based?

Tellus Therapeutics is based in the United States.

Companies like Tellus Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.